149 related articles for article (PubMed ID: 33836365)
1. Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment.
Zhou S; Ma Q; Lou Y; Lv X; Tian H; Wei J; Zhang K; Zhu G; Chen Q; Si T; Wang G; Wang X; Zhang N; Huang Y; Liu Q; Yu X
J Affect Disord; 2021 May; 287():372-379. PubMed ID: 33836365
[TBL] [Abstract][Full Text] [Related]
2. Prediction of early improvement of major depressive disorder to antidepressant medication in adolescents with radiomics analysis after ComBat harmonization based on multiscale structural MRI.
Ma H; Zhang D; Wang Y; Ding Y; Yang J; Li K
BMC Psychiatry; 2023 Jun; 23(1):466. PubMed ID: 37365541
[TBL] [Abstract][Full Text] [Related]
3. Predictors of pharmacotherapy outcomes for body dysmorphic disorder: a machine learning approach.
Curtiss JE; Bernstein EE; Wilhelm S; Phillips KA
Psychol Med; 2023 Jun; 53(8):3366-3376. PubMed ID: 35000652
[TBL] [Abstract][Full Text] [Related]
4. Combining machine learning algorithms for prediction of antidepressant treatment response.
Kautzky A; Möller HJ; Dold M; Bartova L; Seemüller F; Laux G; Riedel M; Gaebel W; Kasper S
Acta Psychiatr Scand; 2021 Jan; 143(1):36-49. PubMed ID: 33141944
[TBL] [Abstract][Full Text] [Related]
5. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
6. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
[TBL] [Abstract][Full Text] [Related]
7. Can Machine-learning Algorithms Predict Early Revision TKA in the Danish Knee Arthroplasty Registry?
El-Galaly A; Grazal C; Kappel A; Nielsen PT; Jensen SL; Forsberg JA
Clin Orthop Relat Res; 2020 Sep; 478(9):2088-2101. PubMed ID: 32667760
[TBL] [Abstract][Full Text] [Related]
8. Assessment of functional outcomes by Sheehan Disability Scale in patients with major depressive disorder treated with duloxetine versus selective serotonin reuptake inhibitors.
Sheehan DV; Mancini M; Wang J; Berggren L; Cao H; Dueñas HJ; Yue L
Hum Psychopharmacol; 2016 Jan; 31(1):53-63. PubMed ID: 26331440
[TBL] [Abstract][Full Text] [Related]
9. Early antidepressant treatment response prediction in major depression using clinical and TPH2 DNA methylation features based on machine learning approaches.
Chen B; Jiao Z; Shen T; Fan R; Chen Y; Xu Z
BMC Psychiatry; 2023 May; 23(1):299. PubMed ID: 37127594
[TBL] [Abstract][Full Text] [Related]
10. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
[TBL] [Abstract][Full Text] [Related]
11. Interpretable machine learning model to predict rupture of small intracranial aneurysms and facilitate clinical decision.
Xiong W; Chen T; Li J; Xiang L; Zhang C; Xiang L; Li Y; Chu D; Wu Y; Jie Q; Qiu R; Xu Z; Zou J; Fan H; Zhao Z
Neurol Sci; 2022 Nov; 43(11):6371-6379. PubMed ID: 35997829
[TBL] [Abstract][Full Text] [Related]
12. Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants.
Nelson JC; Zhang Q; Kelin K; Eriksson E; Deberdt W; Berk M
Curr Med Res Opin; 2013 Jul; 29(7):827-33. PubMed ID: 23581532
[TBL] [Abstract][Full Text] [Related]
13. Can Predictive Modeling Tools Identify Patients at High Risk of Prolonged Opioid Use After ACL Reconstruction?
Anderson AB; Grazal CF; Balazs GC; Potter BK; Dickens JF; Forsberg JA
Clin Orthop Relat Res; 2020 Jul; 478(7):0-1618. PubMed ID: 32282466
[TBL] [Abstract][Full Text] [Related]
14. Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression.
Guilloux JP; Bassi S; Ding Y; Walsh C; Turecki G; Tseng G; Cyranowski JM; Sibille E
Neuropsychopharmacology; 2015 Feb; 40(3):701-10. PubMed ID: 25176167
[TBL] [Abstract][Full Text] [Related]
15. GWAS-based machine learning approach to predict duloxetine response in major depressive disorder.
Maciukiewicz M; Marshe VS; Hauschild AC; Foster JA; Rotzinger S; Kennedy JL; Kennedy SH; Müller DJ; Geraci J
J Psychiatr Res; 2018 Apr; 99():62-68. PubMed ID: 29407288
[TBL] [Abstract][Full Text] [Related]
16. A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder.
Khodayari-Rostamabad A; Reilly JP; Hasey GM; de Bruin H; Maccrimmon DJ
Clin Neurophysiol; 2013 Oct; 124(10):1975-85. PubMed ID: 23684127
[TBL] [Abstract][Full Text] [Related]
17. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Antidepressant Treatment Response and Remission Using an Ensemble Machine Learning Framework.
Lin E; Kuo PH; Liu YL; Yu YW; Yang AC; Tsai SJ
Pharmaceuticals (Basel); 2020 Oct; 13(10):. PubMed ID: 33065962
[TBL] [Abstract][Full Text] [Related]
19. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials.
Machado M; Einarson TR
J Clin Pharm Ther; 2010 Apr; 35(2):177-88. PubMed ID: 20456736
[TBL] [Abstract][Full Text] [Related]
20. Can Minnesota Multiphasic Personality Inventory-2 predict response to selective serotonin reuptake inhibitors in depressed outpatients?
Kertzman S; Vainder M; Reznik I; Gotzlav Y; Weizman A; Kotler M; Iancu I
Int Clin Psychopharmacol; 2012 May; 27(3):134-41. PubMed ID: 22415223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
